Search

Search Results
Results 18041 - 18050 of 18105 for stroke
  • Accupril
    Drug - 2 Sep 2022
    Consumer Medicine Information (CMI) about Accupril intended for persons living in Australia.
  • Adenoscan
    Drug - 31 Aug 2022
    Consumer Medicine Information (CMI) about Adenoscan intended for persons living in Australia.
  • Adenocor
    Drug - 31 Aug 2022
    Consumer Medicine Information (CMI) about Adenocor intended for persons living in Australia.
  • Reaptan
    Drug - 2 Aug 2022
    Consumer Medicine Information (CMI) about Reaptan (Perindopril/amlodipine [pronounced per-in-do-pril/ am-load-i-peen]) intended for persons living in Australia.
  • Revolade
    Drug - 29 Jul 2022
    Consumer Medicine Information (CMI) about Revolade (Eltrombopag olamine) intended for persons living in Australia.
  • Accuretic
    Drug - 27 Jul 2022
    Consumer Medicine Information (CMI) about Accuretic intended for persons living in Australia.
  • Lucentis
    Drug - 6 Jul 2022
    Consumer Medicine Information (CMI) about Lucentis intended for persons living in Australia.
  • DBL Glyceryl Trinitrate
    Drug - 27 Jun 2022
    Consumer Medicine Information (CMI) about DBL Glyceryl Trinitrate intended for persons living in Australia.
  • Imrest
    Drug - 21 Jun 2022
    Consumer Medicine Information (CMI) about Imrest intended for persons living in Australia.
  • Clofen
    Drug - 8 Jun 2022
    Consumer Medicine Information (CMI) about Clofen intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback